Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Dry Eye Medication Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's offering.
The global dry eye medication market is expected to grow from $2,892.8 million in 2015 to $ 3,245.6 million in 2020 at a compound annual growth rate (CAGR) of 2.3%%.
The market is expected to grow at a CAGR of 8.2% to nearly $4,806.0 million by 2025, and at a CAGR of 5.7% to $6,329.7 million by 2030.
Growth in the historic period resulted from an aging population, rising number of contact lens users, increase in disposable income, increase in number of treatment options, increase in number of allergies, rise in consumption of unhealthy or improper diets, and prevalence of diabetes mellitus. Factors that negatively affected growth in the historic period were low healthcare access, and a lack of awareness of the dry eye medication products.
Going forward, rising laser surgeries, rising screen time, busy lifestyles, the increasing burden of diabetes, increase in prevalence of dry eye disease, promising pipeline for dry eye disease, and side effects of other medications will drive growth. Factors that could hinder the growth of the dry eye medication market in the future include long and costly drug approvals, stringent rules and regulations and disruption in the supply chain of drugs related to dry eyes due to the impact of covid-19.
The dry eye medication market is segmented by type of product into aqueous, evaporative and aqueous and evaporative. The aqueous and evaporative market was the largest segment of the dry eye medication market segmented by type of product, accounting for $2,670.9 million or 82.3% of the total in 2020. The evaporative market is expected to be the fastest-growing segment going forward at a CAGR of 8.9% during 2020-2025.
The dry eye medication market is segmented by type of distribution channel into hospital pharmacies, eye health clinics, retail pharmacies and online pharmacies. The retail pharmacies was the largest segment of the dry eye medication market segmented by distribution channel, accounting for $2,063.9 million or 63.6% of the total in 2020. The online pharmacies market is expected to be the fastest-growing segment going forward at a CAGR of 14.3%.
The dry eye medication market is segmented by prescription type into OTC drugs, and prescription drugs. The OTC drugs was the largest segment of the dry eye medication market segmented by prescription type, accounting for $1,723.1 million or 53.1% of the total in 2020. The prescription drugs market is expected to be the fastest-growing segment going forward at a CAGR of 10.1% during 2020-2025.
The dry eye medication market is segmented by drug variation into branded drugs, and generic drugs. The branded drugs segment was the largest segment of the dry eye medication market segmented by drug variation, accounting for $2,070.7 million or 63.8% of the total in 2020. Going forward, the generic drugs is expected to be the fastest-growing segment at a CAGR of 10.3% during 2020-2025.
The dry eye medication market is segmented by delivery system into liquid drops, gel, eye ointment and others. The liquid drops were the largest segment of the dry eye medication market segmented by delivery system, accounting for $3,164.8 million or 97.5% of the total in 2020. The eye ointment market is expected to be the fastest-growing segment going forward at a CAGR of 23.2%.
North America was the largest region in the dry eye medication market, accounting for 31.3% of the global market in 2020. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest growing regions in the dry eye medication market will be the Middle East and Africa, where growth will be at CAGRs of 20.2% and 12.1% respectively. These will be followed by Western Europe and North America where the markets are expected to grow at CAGRs of 8.3% and 7.6% respectively.
The dry eye medication market is highly concentrated, with a small number of large players. The top ten competitors in the market made up to 78.16% of the total market in 2019. Major players in the market include Allergan plc, Alcon Inc, Bausch Health Companies Inc., Novartis AG, Otsuka Holdings Co, Ltd. and others.
Key Topics Covered:
1. Dry Eye Medication Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
7. Dry Eye Medication Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Prescription Type
7.2.1. OTC Drugs
7.2.2. Prescription Drugs
7.3. Market Segmentation By Drug Variation
7.3.1. Branded
7.3.2. Generic
7.4. Market Segmentation By Type Of Product
7.4.1. Aqueous
7.4.2. Evaporative
7.4.3. Aqueous and Evaporative
7.5. Market Segmentation By Distribution Channel
7.5.1. Hospital Pharmacies
7.5.2. Eye Health Clinics
7.5.3. Retail Pharmacies
7.5.4. Online Pharmacies
7.6. Market Segmentation By Delivery System
7.6.1. Liquid
7.6.2. Gel
7.6.3. Ointment
7.6.4. Others
8. Dry Eye Medication Market Supply Chain Analysis
8.1. Raw Material Suppliers
8.2. Contract Research Organization (CRO)
8.3. Dry Eye Drugs Manufacturer
8.3.1. Drug Discovery
8.3.2. Preclinical and Clinical Trials
8.3.3. Patents Upon Discovery and Approval
8.3.4. Drug Manufacturing
8.4. Contract Manufacturing Organization (CMO)
8.5. Wholesalers/Distributors
8.6. Retailers (Pharmacies) and Hospitals
8.7. Ophthalmologists and Optometrists
8.8. End-Users
9. Dry Eye Medication Market Product Analysis - Product Examples
10. PVA TEARST
10.1.1. Santen Pharmaceutical Co., Ltd
10.1.2. Sun Pharmaceuticals Industries, Ltd.
11. Dry Eye Medication Market Customer Information
11.1. Dry Eye Conditions Among Contact Lens Users and Non-Lens Users
11.2. Loss Of Vision Is The Major Concern For Glaucoma Patients
11.3. Majority Of The Patients Do not Seek Preventive Eye Care
11.4. Impact Of Dry Eye Disease (DED) On Patients' Quality Of Life
11.5. Two-thirds Of Americans Suffer From Eye Problems
12. Dry Eye Medication Market Trends and Strategies
12.1. Single Dose Preservative Free Eye Drops
12.2. Development Of New Mode Of Delivery Systems
12.3. New Product Development
12.4. Rising Research and Collaborations
12.5. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) For Dry Eye Treatment
12.6. Development Of Combination Therapies
12.7. Global Expansion and Acquisitions
12.8. Incorporation of modern techniques
12.9. Nasal Spray therapeutics for treating dry eye
13. Impact Of COVID-19 On The Dry Eye Medication Market
13.1. Consumer Perception
13.2. Occurrence Of Conjunctivitis In COVID-19 Patients
13.3. Drugs Used In COVID-19 Patients Are Likely To Develop Eye Risks
13.4. Effect Of Screens
13.5. Severe Eye Abnormalities
14. Unmet Needs In Dry Eye Medication Market
14.1. Diagnostic Challenges Leading to Improper Treatment Decisions
14.2. Low Insurance Coverage For Dry Eye Medications
14.3. Variations In The Availability Of Dry Eye Drugs Across Countries
14.4. Poor Compliance and High Rates Of Discontinuation Of Dry Eye Drugs
15. Dry Eye Medication Market, Pricing Analysis
15.1. Pricing Analysis Of Prescription Drugs
15.2. Pricing Analysis Of Over The Counter Drugs
16. Overview On Dry Eye Disease, Symptoms, and Line Of Treatment Options
16.1. Dry Eye Disease Overview
16.2. Causes and Symptoms of Dry Eyes
16.3. Treatment Options For Dry Eye Disease
16.3.1. Mild Dry Eye Symptoms
16.3.2. Moderate Dry Eye Symptoms
16.3.3. Moderate To Severe Dry Eye Symptoms
Companies Mentioned
- Santen Pharmaceutical Co., Ltd.
- Sentiss Pharma Pvt. Ltd.
- OASIS Medical, Inc.
- VISUfarma B.V.
- Sun Pharmaceutical Industries Limited
- Bayer AG
- Pfizer
- Johnson & Johnson
- Daiichi Sankyo
- ERC Labs
- Vision gain
- Medicom Health care
- Implandata ophthalmic products GmbH
- The Geuder Group
- Novamedika
- Aflofarm Farmacja Polska
- VUAB Pharma, Inc.
- Endo International plc
- Aurinia Pharmaceuticals Inc
- Herzig Eye Institute
- Thomas Eye Group
- Alimera Sciences
- Eyegate
- Neurotech
- Opthotech
- Eyepoint pharmaceuticals
- Gama Vision
- Biolab Pharma
- Mitotech
- Novaliq GmbH
- Horus Pharma
- Prestige Consumer Healthcare, Inc
- Azura Ophthamics, Ltd
- Similasan
- Hoya Corporation
- Adcock Ingram
For more information about this report visit https://www.researchandmarkets.com/r/is6mzb